周建 陈荣荣.头孢噻肟结合中成药对婴幼儿肺炎C-反应蛋白的影响[J].实用中西医结合临床,2008,(4):11-12 |
头孢噻肟结合中成药对婴幼儿肺炎C-反应蛋白的影响 |
|
|
DOI: |
中文关键词: 头孢噻肟 中成药 婴幼儿 肺炎 C-反应蛋白(CRP) |
英文关键词: Cefotaxime Chinese medicine Infants Pneumonia C-reaction Protein(CRP) |
基金项目: |
|
摘要点击次数: 624 |
全文下载次数: 279 |
中文摘要: |
目的:探讨头孢噻肟结合中成药对婴幼儿肺炎患儿血C-反应蛋白(CRP)水平的影响。方法:对未能住院的42例婴幼儿肺炎采用头孢噻肟结合中成药治疗,并对其治疗前及治疗7d后的血CRP水平、临床症状和体征等进行评估。结果:总有效率为81.0%;血CRP水平从治疗前的(45.27±15.70)mg·L-1降至(10.38±7.26)mg·L-1,前后比较有统计学差异(P <0.01)。结论:头孢噻肟结合中成药对婴幼儿肺炎患儿的血CRP有较好的干预效果,该方法治疗婴幼儿肺炎是可取的、有效的、安全的。 |
英文摘要: |
Objective:To explore the intervention of Cefotaxime on C-reaction protein(CRP)in infants with pneumonia.Method:Forty two outpatiengt infants with pneumonia were curad with Cefotaximec. The levels of serum CRP, clinical symptoms and physical signs were evaluated before therapy and 7days after therapy. Result:The effective rate was 81.0%. The mean level of serum CRP before therapy was (45.27±15.70)mg·L-1,and it decreased to (10.38±7.26)mg·L-17days after therapy. There was statistical differenece(P <0.01).Conclusion:Cefotaxime has good intervention effects on serumn CRP in infants with pneumonia.It is acceptable,effective and safe to infants with pneumonia. |
查看全文
查看/发表评论 下载PDF阅读器 |
关闭 |